125 related articles for article (PubMed ID: 23536559)
1. The 19th annual Prostate Cancer Foundation scientific retreat.
Walia G; Pienta KJ; Simons JW; Soule HR
Cancer Res; 2013 Aug; 73(16):4988-91. PubMed ID: 23536559
[TBL] [Abstract][Full Text] [Related]
2. The 21st Annual Prostate Cancer Foundation Scientific Retreat report.
Miyahira AK; Simons JW; Soule HR
Prostate; 2015 Aug; 75(11):1119-28. PubMed ID: 25893521
[TBL] [Abstract][Full Text] [Related]
3. The 26th Annual Prostate Cancer Foundation Scientific Retreat Report.
Miyahira AK; Soule HR
Prostate; 2021 Jan; 81(1):3-19. PubMed ID: 33085787
[TBL] [Abstract][Full Text] [Related]
4. The 23rd Annual Prostate Cancer Foundation Scientific Retreat report.
Miyahira AK; Soule HR
Prostate; 2017 Jul; 77(10):1093-1106. PubMed ID: 28503903
[TBL] [Abstract][Full Text] [Related]
5. The 17th Annual Prostate Cancer Foundation scientific retreat: meeting report.
Ericson KR; Simons JW; Soule HR
Prostate; 2011 Nov; 71(15):1616-20. PubMed ID: 21394742
[TBL] [Abstract][Full Text] [Related]
6. The 28th Annual Prostate Cancer Foundation Scientific Retreat report.
Miyahira AK; Soule HR
Prostate; 2022 Oct; 82(14):1346-1377. PubMed ID: 35852016
[TBL] [Abstract][Full Text] [Related]
7. The 20th Annual Prostate Cancer Foundation Scientific Retreat report.
Miyahira AK; Simons JW; Soule HR
Prostate; 2014 Jun; 74(8):811-9. PubMed ID: 24719035
[TBL] [Abstract][Full Text] [Related]
8. The 24th Annual Prostate Cancer Foundation scientific retreat report.
Miyahira AK; Soule HR
Prostate; 2018 Sep; 78(12):867-878. PubMed ID: 29761524
[TBL] [Abstract][Full Text] [Related]
9. The 29th Annual Prostate Cancer Foundation Scientific Retreat Report.
Miyahira AK; Soule HR
Prostate; 2024 Feb; 84(2):113-130. PubMed ID: 37915138
[TBL] [Abstract][Full Text] [Related]
10. The 22nd annual prostate cancer foundation scientific retreat report.
Miyahira AK; Simons JW; Soule HR
Prostate; 2016 Sep; 76(12):1037-52. PubMed ID: 27272144
[TBL] [Abstract][Full Text] [Related]
11. The 25th Annual Prostate Cancer Foundation Scientific Retreat Report.
Miyahira AK; Soule HR
Prostate; 2019 Sep; 79(12):1471-1486. PubMed ID: 31334865
[TBL] [Abstract][Full Text] [Related]
12. The 27th Annual Prostate Cancer Foundation Scientific Retreat Report.
Miyahira AK; Soule HR
Prostate; 2021 Nov; 81(15):1107-1124. PubMed ID: 34469608
[TBL] [Abstract][Full Text] [Related]
13. Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy Meeting.
Miyahira AK; Cheng HH; Abida W; Ellis L; Harshman LC; Spratt DE; Simons JW; Pienta KJ; Soule HR
Prostate; 2017 Nov; 77(15):1478-1488. PubMed ID: 28925066
[TBL] [Abstract][Full Text] [Related]
14. Tumor cell heterogeneity and resistance; report from the 2018 Coffey-Holden Prostate Cancer Academy Meeting.
Miyahira AK; Den RB; Carlo MI; de Leeuw R; Hope TA; Karzai F; McKay RR; Salami SS; Simons JW; Pienta KJ; Soule HR
Prostate; 2019 Feb; 79(3):244-258. PubMed ID: 30381857
[TBL] [Abstract][Full Text] [Related]
15. Beyond immune checkpoint blockade: new approaches to targeting host-tumor interactions in prostate cancer: report from the 2014 Coffey-Holden prostate cancer academy meeting.
Miyahira AK; Kissick HT; Bishop JL; Takeda DY; Barbieri CE; Simons JW; Pienta KJ; Soule HR
Prostate; 2015 Mar; 75(4):337-47. PubMed ID: 25358693
[TBL] [Abstract][Full Text] [Related]
16. Beyond Seed and Soil: Understanding and Targeting Metastatic Prostate Cancer; Report From the 2016 Coffey-Holden Prostate Cancer Academy Meeting.
Miyahira AK; Roychowdhury S; Goswami S; Ippolito JE; Priceman SJ; Pritchard CC; Sfanos KS; Subudhi SK; Simons JW; Pienta KJ; Soule HR
Prostate; 2017 Feb; 77(2):123-144. PubMed ID: 27679977
[TBL] [Abstract][Full Text] [Related]
17. DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance.
Huber RM; Lucas JM; Gomez-Sarosi LA; Coleman I; Zhao S; Coleman R; Nelson PS
Oncotarget; 2015 Feb; 6(4):2134-47. PubMed ID: 25575823
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathology and prostate cancer therapeutics: from biology to bedside.
Rodrigues DN; Butler LM; Estelles DL; de Bono JS
J Pathol; 2014 Jan; 232(2):178-84. PubMed ID: 24108540
[TBL] [Abstract][Full Text] [Related]
19. Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.
Leach DA; Need EF; Toivanen R; Trotta AP; Palethorpe HM; Tamblyn DJ; Kopsaftis T; England GM; Smith E; Drew PA; Pinnock CB; Lee P; Holst J; Risbridger GP; Chopra S; DeFranco DB; Taylor RA; Buchanan G
Oncotarget; 2015 Jun; 6(18):16135-50. PubMed ID: 25965833
[TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicles released by mesenchymal-like prostate carcinoma cells modulate EMT state of recipient epithelial-like carcinoma cells through regulation of AR signaling.
El-Sayed IY; Daher A; Destouches D; Firlej V; Kostallari E; Maillé P; Huet E; Haidar-Ahmad N; Jenster G; de la Taille A; Abou Merhi R; Terry S; Vacherot F
Cancer Lett; 2017 Dec; 410():100-111. PubMed ID: 28935391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
